PURPOSE: World Trade Center (WTC) exposure caused airflow obstruction years after exposure. Chitinases and IgE are innate and humoral mediators of obstructive airway disease. We investigated if serum expression of chitinases and IgE early after WTC exposure predicts subsequent obstruction. METHODS: With a nested case-control design, 251 FDNY personnel had chitotriosidase, YKL-40 and IgE measured in serum drawn within months of 9/11/2001. The main outcome was subsequent Forced Expiratory Volume after 1 second/Forced Vital Capacity (FEV1/FVC) less than the lower limit of normal (LLN). Cases (N = 125) had abnormal FEV1/FVC whereas controls had normal FEV1/FVC (N = 126). In a secondary analysis, resistant cases (N = 66) had FEV1 (≥107%) one standard deviation above the mean. Logistic regression adjusted for age, BMI, exposure intensity and post-exposure FEV1/FVC modeled the association between early biomarkers and later lung function. RESULTS: Cases and Controls initially lost lung function. Controls recovered to pre-9/11 FEV1 and FVC while cases continue to decline. Cases expressed lower serum chitotriosidase and higher IgE levels. Increase in IgE increased the odds of airflow obstruction and decreased the odds of above average FEV1. Alternately, increasing chitotriosidase decreased the odds of abnormal FEV1/FVC and increased the odds of FEV1 ≥ 107%. Serum YKL-40 was not associated with FEV1/FVC or FEV1 in this cohort. CONCLUSIONS: Increased serum chitotriosidase reduces the odds of developing obstruction after WTC-particulate matter exposure and is associated with recovery of lung function. Alternately, elevated IgE is a risk factor for airflow obstruction and progressive lung function decline.
PURPOSE: World Trade Center (WTC) exposure caused airflow obstruction years after exposure. Chitinases and IgE are innate and humoral mediators of obstructive airway disease. We investigated if serum expression of chitinases and IgE early after WTC exposure predicts subsequent obstruction. METHODS: With a nested case-control design, 251 FDNY personnel had chitotriosidase, YKL-40 and IgE measured in serum drawn within months of 9/11/2001. The main outcome was subsequent Forced Expiratory Volume after 1 second/Forced Vital Capacity (FEV1/FVC) less than the lower limit of normal (LLN). Cases (N = 125) had abnormal FEV1/FVC whereas controls had normal FEV1/FVC (N = 126). In a secondary analysis, resistant cases (N = 66) had FEV1 (≥107%) one standard deviation above the mean. Logistic regression adjusted for age, BMI, exposure intensity and post-exposure FEV1/FVC modeled the association between early biomarkers and later lung function. RESULTS: Cases and Controls initially lost lung function. Controls recovered to pre-9/11 FEV1 and FVC while cases continue to decline. Cases expressed lower serum chitotriosidase and higher IgE levels. Increase in IgE increased the odds of airflow obstruction and decreased the odds of above average FEV1. Alternately, increasing chitotriosidase decreased the odds of abnormal FEV1/FVC and increased the odds of FEV1 ≥ 107%. Serum YKL-40 was not associated with FEV1/FVC or FEV1 in this cohort. CONCLUSIONS: Increased serum chitotriosidase reduces the odds of developing obstruction after WTC-particulate matter exposure and is associated with recovery of lung function. Alternately, elevated IgE is a risk factor for airflow obstruction and progressive lung function decline.
Authors: Michael D Weiden; Natalia Ferrier; Anna Nolan; William N Rom; Ashley Comfort; Jackson Gustave; Rachel Zeig-Owens; Shugi Zheng; Roberta M Goldring; Kenneth I Berger; Kaitlyn Cosenza; Roy Lee; Mayris P Webber; Kerry J Kelly; Thomas K Aldrich; David J Prezant Journal: Chest Date: 2009-10-09 Impact factor: 9.410
Authors: F Aminuddin; L Akhabir; D Stefanowicz; P D Paré; J E Connett; N R Anthonisen; J V Fahy; M A Seibold; E G Burchard; C Eng; A Gulsvik; P Bakke; M H Cho; A Litonjua; D A Lomas; W H Anderson; T H Beaty; J D Crapo; E K Silverman; A J Sandford Journal: Hum Genet Date: 2011-12-28 Impact factor: 4.132
Authors: Marco van Eijk; Cindy P A A van Roomen; G Herma Renkema; Anton P Bussink; Laura Andrews; Edward F C Blommaart; Alan Sugar; Arthur J Verhoeven; Rolf G Boot; Johannes M F G Aerts Journal: Int Immunol Date: 2005-10-07 Impact factor: 4.823
Authors: Eugene Agapov; John T Battaile; Rose Tidwell; Ramsey Hachem; G Alexander Patterson; Richard A Pierce; Jeffrey J Atkinson; Michael J Holtzman Journal: Am J Respir Cell Mol Biol Date: 2009-06-02 Impact factor: 6.914
Authors: D S Postma; E R Bleecker; P J Amelung; K J Holroyd; J Xu; C I Panhuysen; D A Meyers; R C Levitt Journal: N Engl J Med Date: 1995-10-05 Impact factor: 91.245
Authors: Rachel Zeig-Owens; Anna Nolan; Barbara Putman; Ankura Singh; David J Prezant; Michael D Weiden Journal: Am J Ind Med Date: 2016-09 Impact factor: 2.214
Authors: Michael D Weiden; Sophia Kwon; Erin Caraher; Kenneth I Berger; Joan Reibman; William N Rom; David J Prezant; Anna Nolan Journal: Semin Respir Crit Care Med Date: 2015-05-29 Impact factor: 3.119
Authors: Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman Journal: Int J Environ Res Public Health Date: 2022-07-01 Impact factor: 4.614
Authors: Sophia Kwon; Barbara Putman; Jessica Weakley; Charles B Hall; Rachel Zeig-Owens; Theresa Schwartz; Brianne Olivieri; Ankura Singh; Maryann Huie; Debra Morrison; Mayris P Webber; Hillel W Cohen; Kerry J Kelly; Thomas K Aldrich; Anna Nolan; David J Prezant; Michael R Shohet; Michael D Weiden Journal: Ann Am Thorac Soc Date: 2016-08
Authors: Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan Journal: Am J Respir Crit Care Med Date: 2021-11-01 Impact factor: 21.405
Authors: Rachel Zeig-Owens; Ankura Singh; Thomas K Aldrich; Charles B Hall; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; Kerry J Kelly; Anna Nolan; David J Prezant; Michael D Weiden Journal: Ann Am Thorac Soc Date: 2018-02
Authors: Soo Jung Cho; Ghislaine C Echevarria; Young Im Lee; Sophia Kwon; Kwan Yong Park; Jun Tsukiji; William N Rom; David J Prezant; Anna Nolan; Michael D Weiden Journal: J Mol Biomark Diagn Date: 2014
Authors: Ines Mack; Andreas Hector; Marlene Ballbach; Julius Kohlhäufl; Katharina J Fuchs; Alexander Weber; Marcus A Mall; Dominik Hartl Journal: Mol Cell Pediatr Date: 2015-02-27